Clinical Trials Browser

Phase 1/2 × Completed × Blastic Plasmacytoid Dendritic Cell Neoplasm × Clear all

NCT02113982 2024-08-01

Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

Phase 1/2 Completed

138 enrolled 23 charts 1 FDA

MyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Leukemia, Myeloid, Acute

NCT00397579 2019-04-23

DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Phase 1/2 Completed

11 enrolled 6 charts

MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blastic Plasmacytoid Dendritic Cell Neoplasm, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute